Abstract:Objective:To investigate the intra-host dynamics of HIV-1 genotypic drug resistance using single genome sequencing (SGS) for better understanding the derivation of drug resistance mutations (DRMs).Methods:Plasma specimens from four individuals experiencing virologic failure (VF) and the frozen plasma samples collected at their baseline of antiretroviral therapy (ART) were used to detect drug resistance by bulk PCR and consensus sequencing. Single genome amplification and sequencing were performed to harvest pol gene fragments with double dilutions of cDNA template. The quasispecies variation and dynamic characteristics of DRMs were analyzed. The obtained pol gene fragments were analyzed to identify transmitted and acquired drug resistance (TDR and ADR) using the Stanford University HIV drug resistance database. Results:Case NA2302-00 carried TDR (M184//G190A) and experienced VF caused by severe DRMs after five months of ART. TDR was not detected in the other three individuals, but CD4 cell counts in them were all below 200 cells/μl. Moreover, ADR occurred and VF was caused in the three patients after 4-6 months of ART. All cases had a high tolerance to lamivudine and efavirenz and two to tenofovir. Totally, 291 SGS sequences of pol gene were obtained from the samples collected at ART baseline and after VF. Minority DRMs (2.4%-2.9%) were identified in the baseline samples of two cases without TDR using SGS technique, but disappeared during follow-up. All 27 SGS sequences from case NA2302-00 carried homogeneous mutation pattern of TDR. SGS sequences obtained after VF indicated complicated quasispecie variation, which evolved into different mutation patterns. Two individuals carried 1-2 mutation patterns in the SGS sequences obtained after VF, while the other two cases respectively carried four and 13 mutation patterns with two majority patterns above 20%. All of the individuals showed well-maintained viral suppression after being switched to the second line regimen of lopinavir/ritonavir. Conclusions:SGS was conducive to unveil the intra-host quasispecies variation and dynamic characteristics of mutations. Under the antimicrobial selection pressure, viruses in infected individuals would evolve adaptively, from which complex patterns of drug resistant mutations could derive. Follow-up and surveillance should be strengthened during the first year after ART, especially for patients at the stage of AIDS.

Single genome sequencing analysis of dynamic characteristics of HIV-1 drug resistance in patients experiencing virologic failure

Intrapatient Evolutionary Dynamics in an Individual Infected with HIV-1 CRF01_AE Who Experienced Periods of Treatment Failure

Dynamics of HIV-1 quasispecies diversity of participants on long-term antiretroviral therapy based on intrahost single-nucleotide variations

Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART

Distinctive Drug-resistant Mutation Profiles and Interpretations of HIV-1 Proviral DNA Revealed by Deep Sequencing in Reverse Transcriptase.

Prevalence of Drug Resistance and Genetic Transmission Networks Among Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Antiretroviral Therapy Failure in Guangxi, China

Drug resistance evolution in patients with human immunodeficiency virus-1 under long-term antiretroviral treatment-failure in Yunnan Province, China

Hiv Drug Resistance And Its Impact On Antiretroviral Therapy In Chinese Hiv-Infected Patients

Genetic Diversity of Hiv-1 and Transmitted Drug Resistance among Newly Diagnosed Individuals with Hiv Infection in Hangzhou, China

Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China

Predictors Of Hiv Virological Failure And Drug Resistance In Chinese Patients After 48 Months Of Antiretroviral Treatment, 2008-2012: A Prospective Cohort Study

The Development of Drug Resistance Mutations K103N Y181C and G190A in Long Term Nevirapine-containing Antiviral Therapy

Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China

Drug Resistance And Virological Failure Among Hiv-Infected Patients After A Decade Of Antiretroviral Treatment Expansion In Eight Provinces Of China

[The Prevalence and Evolution of HIV Drug-Resistant Strains in People Who Live with HIV/AIDS During HIV Antiretroviral Therapy in Shandong Province].

Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV

Impact Of Low-Frequency HIV-1 Drug Resistance Mutations On Antiretroviral Therapy Outcomes

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China

Next generation sequencing-based analysis of evolution of HIV-1 quasispecies in patients initiating antiretroviral therapy during acute infection

Impact of Pretreatment Low-Abundance HIV-1 Drug Resistance on Virological Failure after 1 Year of Antiretroviral Therapy in China.

Delayed identification of treatment failure causes high levels of acquired drug resistance and less future drug options among HIV-1-infected South Indians